首页> 美国卫生研究院文献>Clinical Orthopaedics and Related Research >Periprosthetic Infection Due to Resistant Staphylococci: Serious Problems on the Horizon
【2h】

Periprosthetic Infection Due to Resistant Staphylococci: Serious Problems on the Horizon

机译:抗性葡萄球菌引起的假体周围感染:即将出现的严重问题

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Prosthetic joint infections (PJI) caused by methicillin-resistant staphylococci represent a major therapeutic challenge. We examined the effectiveness of surgical treatment in treating infection of total hip or knee arthroplasty caused by methicillin-resistant staphylococcal strains and the variables influencing treatment success. One hundred and twenty-seven patients were treated at our institution between 1999 and 2006. There were 58 men and 69 women, with an average age of 66 years. Patients were followed for a minimum of 2 years or until recurrence of infection. Débridement and retention of the prosthesis was performed in 35 patients and resection arthroplasty in 92. Débridement controlled the infection in only 37% of cases whereas two-stage exchange arthroplasty controlled the infection in 75% of hips and 60% of knees. Preexisting cardiac disease was associated with a higher likelihood of failure to control infection in all treatment groups. Antibiotic-resistant Staphylococci continue to compromise treatment outcome of prosthetic joint infections, especially in patients with medical comorbidities. New preventive and therapeutic strategies are needed.>Level of Evidence: Level IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.
机译:由耐甲氧西林的葡萄球菌引起的人工关节感染(PJI)代表了主要的治疗挑战。我们检查了外科治疗在治疗由耐甲氧西林的葡萄球菌菌株引起的全髋或膝关节置换术感染中的有效性以及影响治疗成功的变量。我们的机构在1999年至2006年间共收治了127例患者。男性58例,女性69例,平均年龄66岁。随访患者至少2年或直到感染复发。 35例患者进行了清创术和保留假体,92例进行了置换术。清创术仅控制了37%的病例的感染,而两阶段置换关节置换术控制了75%的臀部和60%的膝盖的感染。在所有治疗组中,先前存在的心脏病与无法控制感染的可能性更高。抗生素耐药的葡萄球菌继续损害人工关节感染的治疗结果,特别是在患有合并症的患者中。需要新的预防和治疗策略。>证据水平: IV级,治疗研究。有关证据水平的完整说明,请参见《作者指南》。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号